10-Q: Hain Celestial Reports Q1 Loss Amid Sales Decline, Debt Refinancing

Hain Celestial Group reported a net loss of $20.6 million for the quarter ended September 30, 2025, as net sales decreased by 6.8% year-over-year, while it also amended its credit agreement.

Summary

• Net loss increased to $20.6 million ($0.23 per diluted share) for the three months ended September 30, 2025, compared to $19.7 million ($0.22 per diluted share) in the prior year quarter.
• Net sales decreased by $26.7 million, or 6.8%, to $367.9 million for the three months ended September 30, 2025.
• Organic net sales decreased by $21.0 million, or 5.8%, driven by a 7% decrease in volume/mix, partially offset by a 1% increase in price.
• Gross profit declined by $13.5 million, or 16.6%, to $68.1 million, with gross profit margin falling to 18.5% from 20.7% in the prior year quarter.
• Operating income turned into an operating loss of $6.9 million for the three months ended September 30, 2025, compared to operating income of $3.1 million in the prior year.
• Adjusted EBITDA decreased by 11.8% to $19.7 million from $22.4 million in the prior year quarter.
• The company completed a Fourth Amendment to its Credit Agreement on September 11, 2025, reducing the Revolver size from $700 million to $600 million and increasing interest rates.
• The multi-year Restructuring Program is ongoing, with $14 million in pretax charges incurred this quarter, compared to $5 million in the prior year.
• The company is exploring strategic alternatives for its personal care business to focus on its portfolio of better-for-you food and beverages.
• Disclosure controls and procedures were not effective as of September 30, 2025, due to a material weakness related to goodwill and indefinite-lived intangible asset impairment tests.

Sentiment

Score: 3

Explanation: The company reported a significant decline in net sales and gross profit, leading to an operating loss and increased net loss. While North America EBITDA improved, the International segment saw a sharp decline. The amendments to the credit agreement, including reduced capacity and higher interest rates, along with the disclosed material weakness in internal controls and ongoing substantial legal proceedings, paint a challenging picture.

Positives

• North America Adjusted EBITDA increased by $4.6 million, or 36.5%, to $17.0 million, driven by productivity savings, reduction in SG&A expenses, and pricing and trade efficiencies.
• Selling, general and administrative expenses decreased by $5.8 million, or 8.2%, due to lower employee-related and non-people cost discipline.
• Cash used in operating activities decreased by $2.3 million, primarily due to lower cash utilization for working capital, driven by focused inventory management.
• Free Cash Flow improved by $2.8 million, from negative $16.5 million in the prior year to negative $13.7 million.
• The company was in compliance with all financial covenants under its Credit Agreement as of September 30, 2025.
• A reversal of non-cash charges of $1.113 million was recorded to the allowance for reduction of assets held for sale.

Negatives

• Net loss increased to $20.6 million from $19.7 million year-over-year.
• Net sales decreased by 6.8% to $367.9 million, with organic net sales down 5.8% due to volume/mix declines.
• Gross profit decreased by 16.6%, and gross profit margin declined to 18.5% from 20.7%.
• Operating income turned into an operating loss of $6.9 million.
• International segment Adjusted EBITDA decreased by $7.8 million, or 38.4%, primarily due to lower volume/mix and cost inflation.
• Productivity and transformation costs increased by $3.2 million, or 63.8%, to $8.2 million.
• Interest and other financing expense, net, increased by $1.8 million, or 12.8%, due to higher financing fees related to credit agreement amendments.
• The Revolver size was reduced from $800 million to $600 million through two amendments, and interest rates increased.
• Cash and cash equivalents decreased by $6.5 million to $47.9 million at September 30, 2025.
• Total debt increased by $11.4 million to $716.2 million at September 30, 2025.
• Disclosure controls and procedures were not effective due to a material weakness.

Risks

• Goodwill associated with the U.S. ($312.321 million) and U.K. ($114.021 million) reporting units is at risk of potential impairment if fair value decreases due to expected future cash flows, decreased customer demand, inability to execute business strategies, or general market conditions (e.g., economic downturns, interest rate changes).
• Indefinite-lived intangible assets (Sensible Portions and Spectrum tradenames, aggregate carrying value of $8 million and $11.8 million respectively) remain at risk of impairment in future periods due to unfavorable changes in assumptions, including forecasted future cash flows, discount rates, and macroeconomic factors.
• Ongoing legal proceedings, including securities class actions, stockholder class and derivative actions, and numerous baby food class actions and personal injury lawsuits alleging unsafe heavy metal levels in Earth's Best products, could result in substantial costs or damages not covered by insurance.
• The company operates in a highly regulated environment, and potential liability if products cause illness or physical harm is a risk.
• Challenges and uncertainty from competition, changes to consumer preferences, ability to execute business strategy, supply chain management (including tariffs, raw material availability/pricing), reliance on contract manufacturers and distributors, international operations, outsourcing, geopolitical conflicts, tax matters, and compliance with credit agreement covenants.
• A material weakness in internal control over financial reporting was identified related to the design and operating effectiveness of controls to review projected financial information and key assumptions for goodwill and indefinite-lived intangible asset quantitative impairment tests.

Future Outlook

The multi-year Restructuring Program is expected to be completed by the end of fiscal year 2027, with cumulative pretax charges of $100 million $110 million and annualized pretax savings of $130 million $150 million. The company anticipates remediating the material weakness in internal controls by the end of fiscal 2026. It expects to enter into a definitive agreement to sell its personal care business within 12 months from when it was initially classified as held for sale (Q3 FY2025). Goodwill and indefinite-lived intangible assets remain at risk of impairment in future periods if fair value assumptions or market conditions deteriorate.

Management Comments

• "We are focused on five actions to win in the marketplace and drive growth: aggressively streamlining our portfolio, accelerating brand renovation and innovation, implementing price increases along with broader revenue growth management, driving productivity and working capital efficiency, and enhancing our digital capabilities, inclusive of ecommerce."
• "Our Board of Directors was conducting a comprehensive review of the Company's portfolio with the assistance of our independent financial advisor. The Board is considering a broad range of strategic options to enhance value."
• "We were exploring strategic alternatives regarding our personal care business to focus on our portfolio of better-for-you food and beverages."
• "The Restructuring Program is intended to optimize our portfolio, improve underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth."
• "We believe that our cash flows from operations and borrowing capacity under our Credit Agreement will be adequate to meet anticipated operating and other expenditures for the foreseeable future."
• "We deny the allegations in these lawsuits and contend that its baby foods are safe and properly labeled."

Industry Context

The global economic environment is characterized by inflation volatility, changing consumer behavior, and geopolitical tensions, driving higher supply chain costs and broader business impacts. Tariffs and potential countermeasures further contribute to industry-wide uncertainty. The International segment's baby & kids category experienced industry-wide volume softness in purees in the U.K., indicating broader market challenges. The company's strategic review and divestiture of non-core brands align with a broader industry trend of consumer packaged goods companies streamlining portfolios to focus on higher-growth, higher-margin categories, particularly 'better-for-you' food and beverages.

Comparison to Industry Standards

• The filing notes 'industry-wide volume softness in purees in the U.K.' for the baby & kids category, suggesting that the company's decline in this specific product area within the International segment is consistent with broader market trends rather than unique to Hain Celestial.
• No specific comparable company or project data is provided to assess the company's overall financial results against global benchmarks.

Management Changes

Corporate Governance

Legal Proceedings

• Securities Class Actions: The company and certain former officers are defendants in a consolidated class action (In re The Hain Celestial Group, Inc. Securities Litigation). The Second Circuit reversed and remanded the dismissal on September 29, 2025, and defendants filed a petition for rehearing on October 27, 2025.
• Additional Stockholder Class Action and Derivative Complaints: A consolidated action (In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation) is stayed pending the appeal in the Consolidated Securities Action, with a further status update due November 14, 2025.
• Baby Food Class Action Litigation: Numerous consumer class actions are consolidated (In re Hain Celestial Heavy Metals Baby Food Litigation) alleging unsafe heavy metal levels in Earth's Best products. A motion to dismiss was granted in part (lead, cadmium, mercury, USDA Organic seal claims dismissed) and denied in part (arsenic claims remain).
• Civil Government Enforcement Action: The State of New Mexico ex rel. Balderas v. Nurture, Inc., et al. lawsuit by the New Mexico Attorney General alleges heavy metals in baby food products. The motion to dismiss was denied, and discovery is ongoing.
• Personal Injury Lawsuits (Baby Food): Numerous lawsuits in state and federal courts allege personal injury (e.g., neurological development disorders like autism and ADHD) from ingestion of products due to heavy metals.
• Baby Food Multidistrict Litigation (MDL): Approximately 100 federal cases were transferred to the Northern District of California. Expert discovery has closed, and Rule 702 hearings are scheduled for the week of December 8, 2025.
• Baby Food California State Court Cases (JCCP): Ten personal injury cases are pending in California State Superior Courts. Most are stayed, but discovery is ongoing in two cases (Kaleb R. and Samuel R.) as of September 30, 2025, and a trial is set for March 16, 2026, in Landon R. v. The Hain Celestial Group, Inc., et al.
• Palmquist v. The Hain Celestial Group, Inc.: After a directed verdict for the company was reversed on appeal, the U.S. Supreme Court heard oral argument on November 4, 2025, following the company's successful petition for a writ of certiorari. The case is remanded to Texas state court, with trial continued pending the Supreme Court's decision.
• The company has not recorded a liability for any of these matters as of September 30, 2025, but acknowledges the possibility of substantial costs or damages not covered by insurance.

Stakeholder Impact

• Shareholders: Negative impact due to increased net loss, declining sales, reduced gross profit, and ongoing legal uncertainties. The material weakness in internal controls also poses a concern.
• Employees: Impacted by the Restructuring Program, which includes employee-related costs such as severance for executive officer succession.
• Customers: Potential impact from portfolio streamlining (discontinued brands, exited product categories) and price increases. Baby food customers are directly impacted by the ongoing litigation regarding product safety.
• Creditors: The company amended its credit agreement twice, reducing the revolving credit facility and increasing interest rates, indicating a potentially higher risk profile or tighter lending conditions. Compliance with covenants is maintained, but the changes reflect increased scrutiny.
• Suppliers: Potential impact from supply chain optimization efforts and cost inflation.

Next Steps

• Continue the multi-year growth, transformation, and restructuring program, expected to be completed by the end of fiscal year 2027.
• Remediate the material weakness in internal control over financial reporting by the end of fiscal 2026.
• Continue evaluating the impact of new accounting pronouncements (ASU 2025-07, ASU 2025-06, ASU 2025-05, ASU 2024-03) on future consolidated financial statements.
• Continue evaluating the impact of the One Big Beautiful Bill Act (OBBBA) tax legislation.
• Enter into a definitive agreement to sell the personal care business within 12 months from when it was initially classified as held for sale (Q3 FY2025).
• Await decision from the Second Circuit regarding the petition for panel rehearing or rehearing en banc in the Consolidated Securities Action.
• Provide a further status update on the Consolidated Stockholder Class and Derivative Action by November 14, 2025.
• Continue discovery in the New Mexico Attorney General lawsuit and other baby food personal injury cases.
• Await a decision from the U.S. Supreme Court in Palmquist v. The Hain Celestial Group, Inc.
• The Court will hold Rule 702 hearings during the week of December 8, 2025, in the baby food Multidistrict Litigation (MDL).
• Trial is currently set for March 16, 2026, in Landon R. v. The Hain Celestial Group, Inc., et al.

Key Dates

Recommendation

The company's Q1 2025 results show a clear deterioration in financial performance, with declining net sales, gross profit, and an increased net loss. The International segment, which was expected to contribute to growth, experienced a significant drop in Adjusted EBITDA. The repeated amendments to the credit agreement, resulting in reduced borrowing capacity and higher interest rates, suggest increasing financial pressure and potentially higher risk perception by lenders. Furthermore, the disclosed material weakness in internal controls over financial reporting raises concerns about the reliability of financial reporting. The extensive and ongoing legal proceedings, particularly the baby food litigation, represent a substantial contingent liability and reputational risk. While the company is undertaking a restructuring program and portfolio review, the immediate financial results and governance issues indicate significant headwinds and a challenging outlook, making the stock a 'Sell' for a seasoned investor.

Keywords

Hain Celestial, 10-Q, quarterly report, financial results, net sales, net loss, Adjusted EBITDA, organic sales, gross profit, operating loss, debt, credit agreement, restructuring program, personal care business, divestiture, legal proceedings, baby food litigation, heavy metals, goodwill impairment, intangible assets, internal controls, corporate governance, consumer packaged goods, health and wellness, snacks, baby & kids, beverages, meal preparation